SEC Form 4 · accession 0001022079-17-000090
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen H Rusckowski
Officer — Chairman, President and CEO · Director
Period of report
Mar 2, 2017
Accepted (ET)
Mar 3, 2017 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2017 | A | 47,934 | $98.12 | A | 192,682 | D | |
| Common StockF2,F3 | Mar 2, 2017 | F | 26,891 | $98.12 | D | 165,888 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d).
- F2Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.